Mayo Clin
Surpiya Rao, MD is a quadruple board-certified physician in internal medicine, gastroenterology, obesity, and lifestyle medicine
Not intended for human consumption, therapeutic use, or veterinary use.
Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus
Muscle loss with these medications is multifactorial, related to caloric restriction, anabolic resistance, and hormonal changes
Its main effects include: Increasing lipolysis (fat breakdown) Reducing lipogenesis (fat storage) Improving fat metabolism signaling Doing so without affecting muscle, bone, or glucose regulation Importantly: It does not stimulate growth hormone release It does not rely on pituitary feedback loops It does not act on central appetite pathways This is why it has such a clean safety profile